Furthermore, we have used transcriptomic analyses to identify a distinct type of ICI-associated myositis in patients with thymoma, which is characterized by a dense inflammatory infiltrate in muscle biopsies and activation of the interleukin (IL)-6 and type 2 interferon (IFN) pathways. This evidence concerns the gene IL6 and myositis disease.